Clinical Lymphatic Mapping in Gynecologic Cancers

Charles Levenback, Ate GJ van der Zee, Robert L. Coleman (MD Anderson Cancer Center, University of Texas, Houston, USA)

$273

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

CRC Press
21 February 2022

Medicine: general issues; Anatomy; Oncology; Gynaecology & obstetrics

Lymphatic mapping techniques have proven to be useful to the early detection and safe treatment of endometrial and cervical cancers; however, the techniques have much of value to offer for breast cancer also and particularly for vulvar cancer, where there has been an explosion of interest and research. In the new edition of Clinical Lymphatic Mapping of Gynecologic Cancers, the techniques are fully explained, with consideration of the latest developments and technologies.

Edited by: Charles Levenback, Ate GJ van der Zee, Robert L. Coleman (MD Anderson Cancer Center, University of Texas, Houston, USA)
Imprint: CRC Press
Country of Publication: United Kingdom
Edition: 2nd edition
Dimensions: Height: 280mm, Width: 210mm,
Weight: 450g
ISBN: 9781032186436
ISBN 10: 1032186437
Pages: 146
Publication Date: 21 February 2022
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

List of contributors. Preface. The history of lymphatic mapping: a gynecologic perspective. Lymphatic anatomy: microanatomy and physiology. Lymphatic anatomy: lymphatics of the vulva. Lymphatic anatomy: lymphatics of the cervix. Lymphatic anatomy: lymphatics of the uterus. Lymphatic anatomy: lymphatics of the ovary. Lymphatic anatomy: lymphatics of the breast and axilla. Modalities of detection of sentinel nodes in lymphatic mapping. Ultrastaging of the sentinel node. Sentinel lymph node biopsy of the vulva. Sentinel lymph node mapping in cervical cancer. Sentinel lymph node mapping in breast cancer. Sentinel lymph node biopsy of the endometrium. Impact of sentinel lymph node mapping on quality of life. Radiation oncology considerations. Special considerations. Clinical trial design. Index.

Charles Levenback, MD is Professor and Deputy Chairman, Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA, and formerly Chief Professionalism Officer. In 2017 he shared the Society of Gynecologic Oncology Innovation Award in recognition for his role in the development of sentinel lymph node biopsy in gynecologic oncology patients and his lead investigator role in multiple institutional and national clinical trials. Ate G.J. van der Zee, MD, PhD is Professor of Gynaecological Oncology and Vice President of the Board of Directors, University Medical Center Groningen, The Netherlands. He leads a world-wide consortium (GROINSS-V-II), which performs landmark clinical studies in vulvar cancer, and shared the SGO Innovation Award in 2017. Robert L. Coleman, MD, FACOG, FACS is Chief Scientific Officer, US Oncology Research, The US Oncology Network, McKesson Specialty Health, The Woodlands, TX, USA, and formerly Professor and Ann Rife Cox Chair of the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas MD Anderson Cancer Center and Executive Director of Cancer Network Research.